8 Bloch C, Richard JL. Les The fasting patient has blood taken for routine haematological and biochemical tests and to measure plasma gastrin concentration and is then sedated with diazepam using the same needle. Gentle questioning at this stage may draw a more honest answer on drug compliance. Upper gastrointestinal endoscopy will allow a view of the duodenum, and any ulceration should be biopsied: all the rare causes of non-peptic duodenal ulceration are diagnosed without difficulty under the microscope. Armed with normal results from these tests the doctor knows that the other causes of an ulcer in the duodenum have been eliminated and that the patient has straightforward refractory peptic ulceration.
All patients with a refractory ulcer should be encouraged to stop smoking and to avoid non-steroidal anti-inflammatory drugs, but should they continue treatment with a histamine H2 antagonist? Most of the evidence suggests that prolonged treatment with conventional doses ofcimetidine4 5 or ranitidine will not work, but possibly larger doses may be useful-for example, cimetidine 1600 mg at night6 or ranitidine 300 mg twice daily. 7 Unfortunately, neither of these regimens has been subjected to a controlled clinical trial in patients with refractory ulcers.
Two studies have suggested that tripotassium dicitrato bismuthate may heal refractory ulcers.89 It is not clear how bismuth works but it may clear Campylobacter pylori."' It might thus be worth trying a regimen of tripotassium dicitrato bismuthate plus metronidazole and amoxycillin in these difficult cases."I Misoprostol, a prostaglandin analogue, has been tried with only limited success for refractory ulcers-42% healed with misoprostol compared with 20% with placebo. 12 Omeprazole is not yet available in Britain, but the ability of this inhibitor of hydrogen-potassium adenosine triphosphatase (if given in a dose of at least 30 mg daily) to eliminate all intragastric acidity has achieved virtually total healing of duodenal ulcers after four weeks' treatment. 13 It might thus be argued that this regimen has eliminated all refractory ulcers, and omeprazole has been tested successfully in two studies of refractory ulceration.5 '4 In a double blind comparative study patients with refractory ulcers were either given omeprazole 40 mg every morning or continued to take histamine H2 antagonist in conventional doses5: after four weeks 87% of the ulcers in those treated with omeprazole had healed compared with only 39% of the ulcers in those who continued taking histamine H2 antagonists.
Surgery is not entirely successful for patients with refractory ulcers. A recent study has shown a five year relapse rate of 34% after highly selective vagotomy in patients with refractory ulcers, whereas the rate was only 3% in those patients whose ulcers had responded to histamine H2 antagonists before surgery.'5 There is, however, a suggestion that recurren ulcers in patients who have had unsuccessful highly selective vagotomy do respond to normal doses of a histamine H2 antagonist. 6 Difficult ulcers may always stay difficult. Delayed healing often seems to be followed by early relapse, and it may be impossible to maintain remission with the usual maintenance dose of a histamine H2 antagonist.'4 If patients with this type of aggressive ulceration cannot or will not give up smoking they may require higher than usual doses of a histamine H2 antagonist, long term omeprazole, or intervention by a surgeon with a special interest in gastric surgery. Loans for medical students May exclude talented but poorer students It is not easy to establish a system of financial support for higher education that reconciles the different and sometimes competing needs of students, families, institutions, and the general public. This government's dissatisfaction with the current grant scheme has led to proposals for loans, an idea first considered 30 years ago by the Anderson committee.' The present white paper describes a non-means tested system of loans to "top up" parental and grant contributions, wnich will be frozen from 1990. In addition, students will no longer be eligible for income support or unemployment and housing benefits.
The motives behind the plans are not exclusively economic: another intention is to undermine the so-called "dependency culture." The paper claims that the scheme will "contribute to their [the students'] economic awareness and self reliance." The current eroded value of grants might already have let students develop such qualities but, in any case, why should students not be partially dependent during their formative years? The loans scheme will not remove all dependency for many students but merely shift it from one financial agent to another.
Medical education is expensive, and, unlike many students in other faculties, medical students do not have lengthy vacations in which to supplement their income. A recent survey of medical undergraduates found that two fifths had overdrafts and four fifths required supplementary or housing benefits.2 The prospect of being dependent on loans for five years (or longer for those at, for example, Cambridge, Oxford, and St Andrews) may well serve as a disincentive to study medicine. This will be particularly true for those from lower income groups, and loan schemes in North America and Scandinavia seem to have discouraged less well off students.
I Certainly, the current proportion of medical students from less well off backgrounds cannot have depleted the pool of potential talent from that sector of society. Moreover, the fact that many students regard the selection system as biased does not inspire confidence in the appropriateness of the current composition of the medical student population. I This is not only an issue of equal opportunities but also one of necessity: as the drop in the proportion of 18-21 year olds affects higher education the need to obtain the best students (including graduates) will be even more compelling.
A loan scheme may still exert important and unintended influences on those who are not deterred from pursuing a medical career. Firstly, it may reduce the number of students who choose to do intercalated degrees and limit the range of options available to students for electives. This matters because they are opportunities for students to develop their full potential and extend their otherwise narrow experience. Secondly, career choice may be partly dictated by the wish to pay off loan debts as quickly as possible rather than to fulfil academic and professional aspirations. Some graduates may thus regard general or private practice as more expedient options than, for example, research. Dormant, unfulfilled aspirations may become a subsequent source of frustration. The impact on career choice may be greater on women, who will have to balance even more carefully than at present the needs of family life and career.
The government has justifiably tried to establish a system of financial support that is "responsive to individuals' economic circumstances," and it advocates that "choice . . . should not be inhibited by an obligation to complete repayment of the loan." I doubt, however, if the proposals will either meet these aims or ensure that medicine does not become the province of privileged students. Whatever form of support is introduced (whether it be an adequate non-means tested grant scheme or a tax based loan scheme that is related to the student's income) it must stimulate the recruitment of those who are able and willing to pursue higher education. Financial support for undergraduates is an investment not a favour extended by the government. 
